09:55 AM EST - Acerus Pharmaceuticals Corporation : Announced that the agreement with Endo Ventures Bermuda Limited (an affiliate of Endo International plc) relating to the commercialization of NATESTO™ in the United States and Mexico will be terminated, effective June 30, 2016. Acerus Pharmaceuticals Corporation
shares T.ASP are trading up $0.005 at $0.15.
